A Study to Evaluate the Efficacy and Toxicities of PLX038, in Patients With Locally Advanced or Metastatic Triple-negative Breast Cancer
Status: NOT_YET_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast|Cancer
Interventions: DRUG: PLX038
Sponsor: Institut Curie
Collaborators: ProLynx LLC